Therapeutic approaches to Huntington disease: from the bench to the clinic

NS Caron, ER Dorsey, MR Hayden - Nature Reviews Drug Discovery, 2018 - nature.com
The 25 years since the identification of the gene responsible for Huntington disease (HD)
have stood witness to profound discoveries about the nature of the disease and its …

[HTML][HTML] Huntington disease

NS Caron, GEB Wright, MR Hayden - GeneReviews®[Internet], 2020 - ncbi.nlm.nih.gov
Huntington Disease - GeneReviews® - NCBI Bookshelf US flag An official website of the United
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …

[HTML][HTML] Focus: Death: Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery

S Subramaniam - The Yale journal of biology and medicine, 2019 - ncbi.nlm.nih.gov
A major unresolved problem in neurodegenerative disease is why and how a specific set of
neurons in the brain are highly vulnerable to neuronal death. Multiple pathways and …

Cerebellar degeneration correlates with motor symptoms in Huntington disease

MK Singh‐Bains, NF Mehrabi, T Sehji… - Annals of …, 2019 - Wiley Online Library
Objective Huntington disease (HD) is an autosomal dominant neurodegenerative disorder
characterized by variable motor and behavioral symptoms attributed to major …

Overlap between age-at-onset and disease-progression determinants in Huntington disease

NA Aziz, JMM van der Burg, SJ Tabrizi… - Neurology, 2018 - AAN Enterprises
Objective A fundamental but still unresolved issue regarding Huntington disease (HD)
pathogenesis is whether the factors that determine age at onset are the same as those that …

Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes

LX Cao, JH Yin, G Du, Q Yang, Y Huang - Brain and Behavior, 2024 - Wiley Online Library
Aims Huntington's disease (HD) is a progressive neurodegenerative disorder with
heterogeneous clinical manifestations. Identifying distinct clinical clusters and their relevant …

Preparation, construction and high-throughput automated analysis of human brain tissue microarrays for neurodegenerative disease drug development

MK Singh-Bains, NF Mehrabi, AYS Tan, RLM Faull… - Nature …, 2021 - nature.com
A major challenge in the treatment of neurodegenerative disorders is the translation of
effective therapies from the lab to the clinic. One approach to improve this process is the use …

[HTML][HTML] N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease

FE Layburn, AYS Tan, NF Mehrabi, MA Curtis… - Neurobiology of …, 2022 - Elsevier
Huntington's disease (HD) is caused by a CAG repeat expansion mutation in the gene
encoding the huntingtin (Htt) protein, with mutant Htt protein subsequently forming …

Abnormal brain development in Huntington'disease is recapitulated in the zQ175 knock-in mouse model

C Zhang, Q Wu, H Liu, L Cheng, Z Hou… - Cerebral Cortex …, 2020 - academic.oup.com
Emerging cellular and molecular studies are providing compelling evidence that altered
brain development contributes to the pathogenesis of Huntington's disease (HD). There has …

Validity of irritability in Huntington's disease: A scoping review

J Simpson, M Dale, R Theed, S Gunn, N Zarotti… - Cortex, 2019 - Elsevier
Purpose To scope the literature concerning irritability in Huntington's disease to determine
whether or not irritability is a valid and meaningful construct within this population. Method A …